We describe a case of epileptic encephalopathy (EE) in a young woman with undiagnosed Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency (MCADD), who presented with an early-onset focal motor status epilepticus (SE) then followed by permanent left hemiplegia and drug-resistant epilepsy with neurodevelopmental delay. Throughout her clinical history, recurrent episodes of lethargy, feeding difficulties and clustering seizures occurred, progressing into a super-refractory SE and death at the age of 25 years. Although epilepsy is not a distinctive feature of MCADD, we advise considering this metabolic disease as a possible aetiology of epileptic encephalopathy and hemiconvulsion-hemiplegia-epilepsy syndrome of unknown origin, on the chance to provide a timely and targeted treatment preventing development delay and evolution to SE. Adult patients with epilepsy of unknown aetiology not screened at birth for inborn errors of metabolism, such as MCADD, should be promptly investigated for these treatable conditions.

Epilepsy and inborn errors of metabolism in adults. The diagnostic odyssey of a young woman with Medium‐Chain Acyl‐Coenzyme A Dehydrogenase Deficiency / Cani, Ilaria; Pondrelli, Federica; Licchetta, Laura; Minardi, Raffaella; Giangregorio, Tania; Mostacci, Barbara; Muccioli, Lorenzo; Di Vito, Lidia; Fetta, Anna; Barba, Carmen; Castioni, Carlo Alberto; Bordugo, Andrea; Tinuper, Paolo; Bisulli, Francesca. - In: EPILEPSIA OPEN. - ISSN 2470-9239. - ELETTRONICO. - (2022), pp. 0-0. [10.1002/epi4.12630]

Epilepsy and inborn errors of metabolism in adults. The diagnostic odyssey of a young woman with Medium‐Chain Acyl‐Coenzyme A Dehydrogenase Deficiency

Barba, Carmen
Writing – Review & Editing
;
2022

Abstract

We describe a case of epileptic encephalopathy (EE) in a young woman with undiagnosed Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency (MCADD), who presented with an early-onset focal motor status epilepticus (SE) then followed by permanent left hemiplegia and drug-resistant epilepsy with neurodevelopmental delay. Throughout her clinical history, recurrent episodes of lethargy, feeding difficulties and clustering seizures occurred, progressing into a super-refractory SE and death at the age of 25 years. Although epilepsy is not a distinctive feature of MCADD, we advise considering this metabolic disease as a possible aetiology of epileptic encephalopathy and hemiconvulsion-hemiplegia-epilepsy syndrome of unknown origin, on the chance to provide a timely and targeted treatment preventing development delay and evolution to SE. Adult patients with epilepsy of unknown aetiology not screened at birth for inborn errors of metabolism, such as MCADD, should be promptly investigated for these treatable conditions.
2022
0
0
Cani, Ilaria; Pondrelli, Federica; Licchetta, Laura; Minardi, Raffaella; Giangregorio, Tania; Mostacci, Barbara; Muccioli, Lorenzo; Di Vito, Lidia; Fetta, Anna; Barba, Carmen; Castioni, Carlo Alberto; Bordugo, Andrea; Tinuper, Paolo; Bisulli, Francesca
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1277620
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact